Health Canada advisory on domperidone: Should I avoid prescribing domperidone to women to increase milk production?

Pina Bozzo, Gideon Koren, Shinya Ito

Research output: Contribution to journalShort surveypeer-review

16 Scopus citations

Abstract

Question: I often prescribe domperidone to women as a galactagogue starting at a dose of 30 mg and increasing the dose as needed. In March of this year, Health Canada released an advisory warning of domperidone use and abnormal heart rhythms and sudden cardiac death. Should I cap doses at 30 mg or stop prescribing domperidone all together to these women? Answer: The Health Canada warning is based on 2 studies. The results of the studies are not directly applicable to breastfeeding and should not change the way you normally manage otherwise healthy breastfeeding women.

Original languageEnglish
Pages (from-to)952-953
Number of pages2
JournalCanadian Family Physician
Volume58
Issue number9
StatePublished - Sep 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Health Canada advisory on domperidone: Should I avoid prescribing domperidone to women to increase milk production?'. Together they form a unique fingerprint.

Cite this